Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The Oncologist(2022)10.1093/oncolo/oyac236Source: DataRank Database

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors is a research paper published in The Oncologist (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.12)OA: goldTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Deepak Ravindranathan ORCID,Yuan Liu ORCID,Dylan J. Martini ORCID,Jacqueline T. Brown ORCID,Bassel Nazha ORCID

Live enrichment

PubMed:36427017 PMC:PMC10020802 OpenAlex:https://openalex.org/W4310055236

Emory University

Grant: P30CA138292

National Cancer Institute

National Institutes of Health

FWCI

1.12

Citation Percentile

0.8%

Influential Citations

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://academic.oup.com/oncolo/article-pdf/28/3/239/49806789/oyac236.pdf

GOLDhttps://academic.oup.com/oncolo/article-pdf/28/3/239/49806789/oyac236.pdf

publisherhttps://academic.oup.com/oncolo/article-pdf/28/3/239/49806789/oyac236.pdf

journalhttps://doi.org/10.1093/oncolo/oyac236

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36427017

Fields of Study

Inflammatory Biomarkers in Disease PrognosisRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersMedicineHumansCarcinoma, Renal CellKidney NeoplasmsImmune Checkpoint InhibitorsNeutrophilsEosinophilsRetrospective Studies

MeSH Terms

Immune Checkpoint InhibitorsCarcinoma, Renal CellEosinophilsHumansKidney NeoplasmsNeutrophilsRetrospective Studies

Keywords

MedicineInternal medicineHazard ratioRenal cell carcinomaClinical trialCancerOncologyUnivariate analysisEosinophilMultivariate analysisConfidence intervalImmunotherapyBiomarkerNivolumabCheckpoint Inhibitor

Sustainable Development Goals

SDG 0: Good health and well-being